Back to Search Start Over

Evaluation of ( rac )-, ( R )-, and ( S )- 18 F-OF-NB1 for Imaging GluN2B Subunit-Containing N -Methyl-d-Aspartate Receptors in Nonhuman Primates.

Authors :
Ahmed H
Zheng MQ
Smart K
Fang H
Zhang L
Emery PR
Gao H
Ropchan J
Haider A
Tamagnan G
Carson RE
Ametamey SM
Huang Y
Source :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Dec; Vol. 63 (12), pp. 1912-1918. Date of Electronic Publication: 2022 Jun 16.
Publication Year :
2022

Abstract

Despite 2 decades of research, no N -methyl-d-aspartate (NMDA) glutamate receptor (GluN) subtype 2B (GluN1/2B) radioligand is yet clinically validated. Previously, we reported on ( rac )- <superscript>18</superscript> F-OF-NB1 as a promising GluN1/2B PET probe in rodents and its successful application for the visualization of GluN2B-containing NMDA receptors in postmortem brain tissues of patients with amyotrophic lateral sclerosis. In the current work, we report on the in vivo characterization of ( rac )-, ( R )-, and ( S )- <superscript>18</superscript> F-OF-NB1 in nonhuman primates. Methods: PET scans were performed on rhesus monkeys. Plasma profiling was used to obtain the arterial input function. Regional brain time-activity curves were generated and fitted with the 1- and 2-tissue-compartment models and the multilinear analysis 1 method, and the corresponding regional volumes of distribution were calculated. Blocking studies with the GluN1/2B ligand Co 101244 (0.25 mg/kg) were performed for the enantiopure radiotracers. Receptor occupancy, nonspecific volume of distribution, and regional binding potential ( BP <subscript>ND</subscript> ) were obtained. Potential off-target binding toward σ <subscript>1</subscript> receptors was assessed for ( S )- <superscript>18</superscript> F-OF-NB1 using the σ <subscript>1</subscript> receptor ligand FTC-146. Results: Free plasma fraction was moderate, ranging from 12% to 16%. All radiotracers showed high and heterogeneous brain uptake, with the highest levels in the cortex. ( R )- <superscript>18</superscript> F-OF-NB1 showed the highest uptake and slowest washout kinetics of all tracers. The 1-tissue-compartment model and multilinear analysis 1 method fitted the regional time-activity curves well for all tracers and produced reliable regional volumes of distribution, which were higher for ( R )- than ( S )- <superscript>18</superscript> F-OF-NB1. Receptor occupancy by Co 101244 was 85% and 96% for ( S )- <superscript>18</superscript> F-OF-NB1 and ( R )- <superscript>18</superscript> F-OF-NB1, respectively. Pretreatment with FTC-146 at both a low (0.027 mg/kg) and high (0.125 mg/kg) dose led to a similar reduction (48% and 49%, respectively) in specific binding of ( S )- <superscript>18</superscript> F-OF-NB1. Further, pretreatment with both Co 101244 and FTC-146 did not result in a further reduction in specific binding compared with Co 101244 alone in the same monkey (82% vs. 81%, respectively). Regional BP <subscript>ND</subscript> values ranged from 1.3 in the semiovale to 3.4 in the cingulate cortex for ( S )- <superscript>18</superscript> F-OF-NB1. Conclusion: Both ( R )- and ( S )- <superscript>18</superscript> F-OF-NB1 exhibited high binding specificity to GluN2B subunit-containing NMDA receptors. The fast washout kinetics, good regional BP <subscript>ND</subscript> values, and high plasma free fraction render ( S )- <superscript>18</superscript> F-OF-NB1 an attractive radiotracer for clinical translation.<br /> (© 2022 by the Society of Nuclear Medicine and Molecular Imaging.)

Details

Language :
English
ISSN :
1535-5667
Volume :
63
Issue :
12
Database :
MEDLINE
Journal :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Type :
Academic Journal
Accession number :
35710735
Full Text :
https://doi.org/10.2967/jnumed.122.263977